Send to

Choose Destination
See comment in PubMed Commons below
Cell. 2012 May 11;149(4):731-3. doi: 10.1016/j.cell.2012.04.014.

Network medicine strikes a blow against breast cancer.

Author information

  • 1Biotech Research and Innovation Center, University of Copenhagen, Denmark.


Drug development for complex diseases is shifting from targeting individual proteins or genes to systems-based attacks targeting dynamic network states. Lee et al. now reveal how the progressive rewiring of a signaling network over time following EGF receptor inhibition leaves triple-negative breast tumors vulnerable to a second, later hit with DNA-damaging drugs, demonstrating that time- and order-dependent drug combinations can be more efficacious in killing cancer cells.

Copyright © 2012 Elsevier Inc. All rights reserved.

Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk